Cullinan Therapeutics
Jeff Jones currently serves as the Chief Medical Officer at Cullinan Therapeutics. Previously, Jeff held the position of Vice President of Global Drug Development for Lymphoma and Myeloid at Bristol Myers Squibb and worked as Executive Medical Director at Celgene. Jeff has also contributed to academia as an Associate Professor of Medicine at The Ohio State University and completed a Clinical Fellowship at The University of Texas MD Anderson Cancer Center. Jeff holds a medical degree from the University of Michigan Medical School and an MBA from The Ohio State University Fisher College of Business.
This person is not in the org chart
This person is not in any teams
Cullinan Therapeutics
1 followers
Cullinan Therapeutics is dedicated to creating new standards of care for patients. We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class. Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.